💊 Get Daily Updates on Generic Entry, Litigation, Biosimilars, and More…
Profile for Eagle Pharmaceuticals, Inc. (EGRX)
« Back to company indexEGRX Chatter Timeline
Stock Ticker for EGRX
Most Active Tweeters for EGRX
| User | Tweets |
|---|---|
| @Tickeron | 7 |
| @InsiderAlerts4U | 2 |
| @mehabecapital | 1 |
| @sbwcws | 1 |
| @YouCanFoolMost | 1 |
Recent Tweets for EGRX
 |
@YouCanFoolMost RT @Tickeron: $EGRX's in Uptrend: Moving Average Convergence Divergence (MACD) Histogram crosses above signal line. View odds for this and… April 18th 2021, 2:04am |
 |
@Tickeron $EGRX's in Uptrend: Moving Average Convergence Divergence (MACD) Histogram crosses above signal line. View odds for… https://t.co/Rar78tKUiu April 18th 2021, 2:04am |
|
@Tickeron $EGRX enters an Uptrend because Momentum Indicator exceeded the 0 level on April 13, 2021. View odds for this and o… https://t.co/vWdNGsWsQy April 16th 2021, 1:04pm |
|
@Tickeron $EGRX in Downtrend: 50-day Moving Average crossed below 200-day Moving Average on March 31, 2021. View odds for thi… https://t.co/XqNO8fgqmS April 14th 2021, 12:04pm |
 |
@InsiderAlerts4U $EGRX: New Insider Filing on EAGLE PHARMACEUTICALS, INC.'s Director STEVEN B RATOFF: https://t.co/ELddH9PMOP April 12th 2021, 8:04pm |
 |
@mehabecapital Insider Activity seen in $EGRX, RATOFF STEVEN B (Director) Option Exercise, Total-Shares = 7,020, Transaction Pric… https://t.co/I4H1Z5FHkE April 12th 2021, 8:04pm |
|
@Tickeron $EGRX in Downtrend: 50-day Moving Average crossed below 200-day Moving Average on March 31, 2021. View odds for thi… https://t.co/Ysq0aBfEPU April 12th 2021, 2:04am |
|
@Tickeron $EGRX in Downtrend: 50-day Moving Average broke below 200-day Moving Average on March 31, 2021. View odds for this… https://t.co/iwTnSCmZH3 April 10th 2021, 8:04am |
|
@Tickeron $EGRX in Downtrend: 50-day Moving Average crossed below 200-day Moving Average on March 31, 2021. View odds for thi… https://t.co/CoeVrR2fl8 April 8th 2021, 8:04pm |
 |
@Gambiste1 RT @utbcapital: Who’s looking at $EGRX? April 8th 2021, 2:04pm |
 |
@utbcapital Who’s looking at $EGRX? April 8th 2021, 2:04pm |
|
@InsiderAlerts4U $EGRX: New Insider Filing on EAGLE PHARMACEUTICALS, INC.'s Director STEVEN B RATOFF: https://t.co/CJ1Vkc7e8n April 7th 2021, 10:04pm |
 |
@StockTexts $EGRX Eagle Pharmaceuticals, Inc. SEC Filing: Form 4 https://t.co/eX70GDBA7S April 7th 2021, 10:04pm |
 |
@FlashAlert_me $EGRX [15s. delayed] filed SEC form 4: Director RATOFF STEVEN B: Converted securities 2,340 of Common Stock at pri… https://t.co/ln2YgGaXqL April 7th 2021, 10:04pm |
 |
@sbwcws Eagle Pharmaceuticals transferred with an Outperform at RBC Capital $EGRX April 6th 2021, 8:04pm |
 |
@ChartMill $EGRX: The EPS is expected to grow by 78.44% on average over the next 2 years. This is a very strong growth.… https://t.co/Bjl7Zz2KVr April 6th 2021, 7:04pm |
|
@Tickeron $EGRX in Downtrend: 50-day Moving Average broke below 200-day Moving Average on March 31, 2021. View odds for this… https://t.co/zmf4uRMSBj April 6th 2021, 5:04am |
|
@InsiderAlerts4U $EGRX: New Insider Filing on EAGLE PHARMACEUTICALS, INC.'s CEO SCOTT TARRIFF: https://t.co/Aya7SV180k April 5th 2021, 11:04pm |
|
@StockTexts $EGRX Eagle Pharmaceuticals, Inc. SEC Filing: Form 4 https://t.co/Pzcyh9SC6j April 5th 2021, 8:04pm |
 |
@AlertTrade DOWNSIDE MOMO: $EGRX Eagle Pharmaceuticals, Inc https://t.co/sOktJqMCBx ? ? TradeIdeas via ? https://t.co/VS8RO1bzXJ April 5th 2021, 2:04pm |
 |
@maxm_profit RT @Tickeron: $EGRX in Downtrend: 50-day Moving Average moved below 200-day Moving Average on March 31, 2021. View odds for this and other… April 4th 2021, 9:04am |
|
@Tickeron $EGRX in Downtrend: 50-day Moving Average moved below 200-day Moving Average on March 31, 2021. View odds for this… https://t.co/jc0CNDX4xc April 4th 2021, 12:04am |
|
@Tickeron $EGRX in Downtrend: 50-day Moving Average crossed below 200-day Moving Average on March 31, 2021. View odds for thi… https://t.co/zubb56s69i April 2nd 2021, 9:04am |
|
@Tickeron $EGRX's 10-day Moving Average moved below its 50-day Moving Average on February 19, 2021. View odds for this and ot… https://t.co/mUzySaG37X April 1st 2021, 4:04pm |
|
@Tickeron $EGRX's 10-day Moving Average moved below its 50-day Moving Average on February 19, 2021. View odds for this and ot… https://t.co/w1uZGwqBhZ March 29th 2021, 10:03am |
|
@Tickeron $EGRX's 10-day Moving Average broke below its 50-day Moving Average on February 19, 2021. View odds for this and ot… https://t.co/ml6IqmNTC6 March 28th 2021, 7:03am |
|
@Tickeron $EGRX's 10-day Moving Average moved below its 50-day Moving Average on February 19, 2021. View odds for this and ot… https://t.co/Zs110eZ1GF March 24th 2021, 11:03pm |
|
@Tickeron $EGRX in Uptrend: 50-day Moving Average broke above 200-day Moving Average on December 3, 2020. View odds for this… https://t.co/qJf3NwfrnL March 24th 2021, 12:03pm |
|
@Tickeron $EGRX in Uptrend: 50-day Moving Average moved above 200-day Moving Average on December 3, 2020. View odds for this… https://t.co/nKAAInT5FQ March 22nd 2021, 7:03am |
|
@Tickeron $EGRX in Uptrend: 50-day Moving Average crossed above 200-day Moving Average on December 3, 2020. View odds for thi… https://t.co/Qn8SoLne58 March 20th 2021, 1:03am |
|
@Tickeron $EGRX in Uptrend: 50-day Moving Average broke above 200-day Moving Average on December 3, 2020. View odds for this… https://t.co/stTNO71Qbb March 18th 2021, 4:03am |
|
@Tickeron $EGRX in Uptrend: Stochastic indicator sits in overbought zone for 1 day. View odds for this and other indicators:… https://t.co/8x7RJ4CLQm March 16th 2021, 2:03am |
|
@Tickeron $EGRX in Uptrend: Stochastic indicator remains in overbought zone for 1 day. View odds for this and other indicator… https://t.co/LaF5Yw3eLi March 15th 2021, 5:03am |
|
@Tickeron $EGRX in Uptrend: 50-day Moving Average moved above 200-day Moving Average on December 3, 2020. View odds for this… https://t.co/RgFBg2u7pB March 11th 2021, 10:03pm |
|
@Tickeron $EGRX in Uptrend: 50-day Moving Average broke above 200-day Moving Average on December 3, 2020. View odds for this… https://t.co/XcHD4N3IZW March 11th 2021, 12:03pm |
|
@Tickeron $EGRX in Uptrend: 50-day Moving Average moved above 200-day Moving Average on December 3, 2020. View odds for this… https://t.co/fMlACk9OOH March 10th 2021, 7:03am |
|
@ChartMill $EGRX: The Revenue has been growing by 22.96% on average over the past 5 years. This is a very strong growth!… https://t.co/FtfXNO8qj1 March 9th 2021, 12:03pm |
|
@Tickeron $EGRX's price moved below its 50-day Moving Average on February 11, 2021. View odds for this and other indicators:… https://t.co/zIX43xxest March 7th 2021, 9:03am |
 |
@CSIMarket $EGRX #StockMarket #EaglePharmaceuticals issued fiscal period ending Dec 31 2020 Eps on https://t.co/savSNU1XbB: In… https://t.co/b7tM84vqQT March 6th 2021, 12:03pm |
 |
@newsfilterio Form 10-K (annual report [section 13 and 15(d), not s-k item 405]) filed with the SEC $EGRX https://t.co/lwPGCEbZj2 March 6th 2021, 9:03am |
|
@Tickeron $EGRX enters a Downtrend because Momentum Indicator dropped below the 0 level on February 12, 2021. View odds for t… https://t.co/ECNAzJX0MN March 6th 2021, 5:03am |
|
@AlertTrade MOST ACTIVE: $EGRX Eagle Pharmaceuticals, Inc https://t.co/ZImwkazax2 ? TradeIdeas via ? https://t.co/zWAorADS1w March 5th 2021, 5:03pm |
|
@AlertTrade SOCIAL ACTIVITY: $EGRX - Eagle Pharmaceuticals, Inc https://t.co/xqfdlmt8pP ? TradeIdeas via ? https://t.co/ZgCyz4rX3x March 5th 2021, 5:03pm |
 |
@fintel_io $EGRX / Eagle Pharmaceuticals files form 10-K https://t.co/jjBqBzU6cz March 5th 2021, 2:03pm |
 |
@EdgarInsider A new filing Form 10-K #AnnualReport has been made at the SEC by $EGRX #EaglePharmaceuticals, Inc https://t.co/GJu61Quj4o March 5th 2021, 2:03pm |
|
@FlashAlert_me $EGRX [15s. delayed] filed form 10-K on March 05, 09:07:31 https://t.co/GOvg5FkPNE March 5th 2021, 2:03pm |
|
@Tickeron $EGRX's in Downtrend: Moving Average Convergence Divergence (MACD) Histogram just turned negative. View odds for th… https://t.co/bz8BpCwxQU March 4th 2021, 5:03pm |
 |
@EarningsResults EGRX Stock | Eagle Pharmaceuticals Inc Q4 2020 Earnings Call https://t.co/5HbNUywfku $EGRX #earnings March 4th 2021, 4:03am |
 |
@midetimes Eagle Pharmaceuticals $EGRX Posts Earnings Results, Beats Estimates By $2.38 EPS https://t.co/c2UOEGJtlZ #stocks March 3rd 2021, 5:03pm |
 |
@dailypoliticaln Eagle Pharmaceuticals $EGRX Posts Earnings Results, Beats Estimates By $2.38 EPS https://t.co/Lyf8ZFMUwo March 3rd 2021, 5:03pm |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2021. All rights reserved.
Get the DrugPatentWatch Daily Briefing
Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …
Want insights into the biggest revenue-changing events?
Billions of dollars in sales can evaporate overnight as drug patents expire and competitors enter the market.
By tracking patent expirations, patent litigation, generic and biosimilar development, you can anticipate these market-shaping forces and stay one step ahead.
➤ Free Trial
